The Menopause Rebrand: 6 Myths About Hormone Therapy That Might Be Harming Your Health

The 20+ Year Ripple Effect

For more than 20 years, women’s health has been shaped by a ripple effect that started in 2002 with the Women’s Health Initiative. The headlines that followed were scary and spread quickly, and many women stopped hormone therapy almost overnight. Clinicians became more cautious too, and over time, menopause care quietly took a step back. What followed was a ripple effect of less education, less comfort having these conversations, and a lot of women left trying to push through symptoms that were affecting their sleep, mood, energy, and overall quality of life.

Overall, the Women’s Health Initiative was an important and well-done study, however like most good research, it didn’t tell the whole story on its own. The post hoc analyses that came later helped us better understand the data, showing that age, timing of initiation, and the type and route of hormone therapy all matter. The women in the original study were, on average, older than many women who come in today looking for help with perimenopause or early menopause symptoms, and that distinction is important. Over time, this has led to a much more nuanced and individualized approach to care.

You may also notice a shift in language. Many experts now use the term hormone therapy

instead of hormone replacement therapy, recognizing that menopause is a natural transition, not something that simply needs to be “replaced.” More recently, the FDA announced it is beginning the process of removing the long-standing black boxed warnings on certain hormone therapy products, reflecting a more current understanding of the risks and benefits. This doesn’t mean hormone therapy is right for everyone, but it does mean the conversation is evolving.

This isn’t about swinging from fear to telling everyone they should be on hormones. It’s about

moving toward thoughtful, individualized, evidence-based care. We all deserve more than

outdated headlines. We deserve a conversation that actually fits for all of us.

Myth #1: “Hormone Therapy is Dangerous and Should Be Avoided”

The Fact:

For many healthy women under 60 or within 10 years of menopause, hormone therapy is a

safe and appropriate option.

The Reality:

Much of the fear around hormone therapy came from early interpretation of the Women’s

Health Initiative. The results were often applied more broadly than intended, including to

younger women with menopause symptoms who were very different from the average

participant in that study.

Over time, follow-up studies and additional analyses have helped clarify all of it. What we now understand is that timing matters, age matters, and the type of hormone and how it’s delivered matters. When started earlier in menopause, hormone therapy can have a different risk profile than what was initially assumed.

There is also data suggesting that for some women in their 50s, hormone therapy may be

associated with a reduction in all-cause mortality. That’s a very different message than what

many women heard for years.

Some researchers have raised concerns that the widespread avoidance of hormone therapy

may have had unintended consequences for women’s long-term health. While the exact impact is still debated, it highlights how significant that shift in practice was.

The 2025 Shift:

More recently, the FDA has begun reviewing long-standing boxed warnings on certain hormone therapy products. This reflects a more current, nuanced understanding of risks and benefits.

This doesn’t mean hormone therapy is right for everyone. But it does mean we’ve moved away from blanket fear and toward more individualized, evidence-based care.

Myth #2: “Hormone Therapy Will Double Your Risk of Breast Cancer”

The Fact: The risk is often much smaller than people think, and it depends on the type of

hormone therapy used. For women taking estrogen alone, breast cancer risk may actually be

unchanged or even slightly lower.

The Reality: A lot of the fear comes from how the data was presented. You may have heard

about a “26% increase” in breast cancer risk, but that’s a relative risk, which can sound much

more dramatic than it actually is.

When you look at the absolute risk, the numbers tell a different story. In the Women’s Health

Initiative, this translated to about 8 additional cases per 10,000 women per year using combined hormone therapy (estrogen + progestin). That’s less than 1 extra case per 1,000 women annually. Importantly, even with that small increase in cases, there was no significant increase in deaths from breast cancer.

It’s also worth noting that not all hormone therapy is the same. The WHI studied a specific

synthetic progestin. We now know that different types of progesterone, especially micronized

(bioidentical) progesterone may have a more favorable risk profile, although ongoing research continues to refine this.

Lifestyle factors also play a role. For example, regular alcohol intake and smoking are

well-established risk factors for breast cancer, and in many cases, their impact is greater than the risk seen with some forms of hormone therapy.

The Bottom Line: Risk is not zero, but it’s also not what many women were led to believe.

Context matters, the type of therapy matters, and most importantly, your individual risk matters.

Myth #3: “Hormone Therapy Makes You Gain Weight”

The Fact:

Weight changes in midlife are driven by aging and the menopause transition, and NOT

hormone therapy.

The Reality:

As we get older, our metabolism gradually slows, and body composition shifts. At the same

time, menopause is associated with a tendency to store more fat centrally, what many women notice as increased weight around the midsection.

Hormone therapy itself has not been shown to cause weight gain.

Instead, it can support your body in ways that may indirectly help. Some data suggest it may

limit the shift toward increased abdominal fat, although it’s not a weight loss treatment. It can

also improve symptoms like night sweats and disrupted sleep. When sleep improves, it’s often easier to stay consistent with movement, strength training, and other habits that support overall health.

The Bottom Line:

Midlife weight changes are real, but hormone therapy isn’t the cause. For some women, it can be one piece of a broader approach that helps you feel better and stay consistent with the things that matter most.

Myth #4: “Natural or Bioidentical Hormones Are Safer Than Traditional Ones”

The Fact: “Natural” doesn’t automatically mean safer or better studied.

The Reality: A lot of women are told that “custom-compounded” or “bioidentical” hormones are safer because they’re more natural. Yet most of these products are made by compounding pharmacies and are not FDA-approved, which means they are not held to the same standards for consistency, dosing, and safety as FDA-approved therapies.

That doesn’t mean compounding pharmacies don’t have a role; they can be helpful in certain

situations. These formulations are not routinely tested in the same way, and doses can vary

more than many women realize.

It’s also important to know that many FDA-approved hormone therapies are already bioidentical.

They are derived from plant sources and are chemically identical to the hormones your body

makes, but they’ve been studied, tested, and regulated.

The Bottom Line: “Bioidentical” and “natural” are often marketing terms, not guarantees of

safety. What matters most is using a therapy that is evidence-based, appropriately dosed, and tailored to you.

Myth #5: “You Can Only Stay on Hormone Therapy for 5 Years”

The Fact: There is no strict “expiration date” for hormone therapy. Duration should be

individualized based on your symptoms, health history, and goals.

The Reality: The idea of a “5-year limit” largely came from how the early Women’s Health

Initiative results were interpreted, and not because there was ever a hard medical cutoff. That

thinking stuck, even though it oversimplified a much more nuanced decision.

What we understand now is that there isn’t a one-size-fits-all timeline. Some women may use

hormone therapy for a shorter period, while others may continue longer if the benefits outweigh the risks and they’re doing well.

There are also important exceptions. For women who go through menopause early (before age 45, and especially before 40), staying on hormone therapy until at least the average age of menopause (around 50–51) is often recommended to support bone, heart, and overall health.

The 2025 Shift: More recently, the FDA announced it is beginning the process of updating

long-standing boxed warnings and labeling language around hormone therapy. The shift reflects a move away from blanket rules like “lowest dose for the shortest duration” toward a more individualized, patient-centered approach.

The Bottom Line: There’s no universal stop date. The right duration is the one that continues to make sense for you, based on your symptoms, your health, and an ongoing conversation.

Myth #6: “Hormone Therapy Is Only for Hot Flashes”

The Fact: Hormone therapy is the most effective treatment for hot flashes, but its impact goes

beyond symptom relief.

The Reality: Yes, hormone therapy is the gold standard for treating hot flashes and night

sweats. But it can also play an important role in other areas of health.

Brain Health: Some research suggests hormone therapy may support brain health and could

be associated with a lower risk of cognitive decline when started around the time of menopause, but this is still an area of ongoing study, and results are mixed.

Bone Health: Hormone therapy has been consistently shown to help maintain bone density and significantly reduce the risk of fractures, which is especially important as we age.

Heart Health: For heart health, timing matters. When started earlier in menopause—generally under age 60 or within 10 years of the final period—hormone therapy is associated with a lower risk of coronary heart disease and a more favorable overall cardiovascular profile compared to starting later.

This is often referred to as a “window of opportunity,” meaning that starting hormone therapy

closer to menopause is associated with more benefit and lower risk.

As blood vessels age and atherosclerosis develops, the response to hormone therapy appears to change, which helps explain why starting later does not carry the same potential benefit.

The Bottom Line: Hormone therapy isn’t just about symptom relief, but it’s also not a

one-size-fits-all prevention strategy. The benefits and risks depend on your timing, your health, and your goals.

Conclusion: Reclaiming the Conversation

For a long time, fear shaped the conversation around hormone therapy. For many women, that meant pushing through symptoms, second-guessing options, or not realizing there were options at all.

What’s become clearer over time is that this is not a one-size-fits-all decision, and it was never meant to be.

The conversation has shifted, not toward telling everyone they should take hormones, but

toward making space for a more thoughtful, individualized approach.

Midlife is a transition, but it’s also a long stretch of life ahead.

Understanding what’s happening in your body and knowing what options exist can change how you move through it.